Litcius/Paper detail

Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

Sytske Anne Bergstra, Alexandre Sepriano, Andreas Kerschbaumer, Désirée van der Heijde, Roberto Caporali, Christopher J Edwards, Patrick Verschueren, Savia de Souza, Janet Pope, Tsutomu Takeuchi, Kimme L Hyrich, Kevin Winthrop, Daniel Aletaha, Tanja Stamm, Jan W. Schoones, Josef S Smolen, Robert Landewé

2022Annals of the Rheumatic Diseases103 citationsDOIOpen Access PDF

Topics & Concepts

MedicineRheumatoid arthritisInternal medicineObservational studyClinical trialPrednisonePharmacoepidemiologyDiabetes mellitusIntensive care medicinePharmacologyMedical prescriptionEndocrinologyRheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus ResearchPeripheral Neuropathies and Disorders
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis | Litcius